Point72 Asia (Singapore)’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
EC
SB
RI
RG
GPP
APM
CC
Point72 Asia (Singapore)'s NGNE Position: Q2 2024 in Review
Point72 Asia (Singapore) sold out of Neurogene (NGNE) in Q2 2024, closing a stake of 5,004 shares — an estimated $255K sold.
Point72 Asia (Singapore) first reported a position in NGNE in Q1 2024 and held it in 1 quarter. The position peaked at $255K in Q1 2024. 66 funds tracked by Wall St. Rank hold NGNE as of Q2 2024.
- Point72 Asia (Singapore) reported no remaining Neurogene position as of Q2 2024 after selling out during the quarter.
- Point72 Asia (Singapore) sold 5,004 Neurogene shares in Q2 2024, an estimated $255K.
- Point72 Asia (Singapore) first reported a position in Neurogene in Q1 2024 and held it in 1 quarter.
- Point72 Asia (Singapore)'s Neurogene position peaked at $255K in Q1 2024.
- 66 funds tracked by Wall St. Rank held Neurogene as of Q2 2024.
Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.